Due to a national shortage of blood collection tubes, you may experience upwards of a 2-hour delay in processing time for certain tests. Someone from our team will advise you if your scheduled lab test is affected by this delay. We thank you in advance for your patience.

Clinical Trials & Research

PH3 pral(Blu-667) RET-fusion mNSCLC

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

Disease Types: Lung (Non Small Cell),&nbs

Available at: {clinical_trial_location backspace="7"}PH3 pral(Blu-667) RET-fusion mNSCLC, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}